Kure Therapeutics Inc

OKUR05 Dec 2024
Healthcare
$14.6
-0.03 (-3.35%)
Lowest Today
$14
Highest Today
$14.75
Today’s Open
$14.6
Prev. Close
$14.63
52 Week High
$77.6
52 Week Low
$9.8
To Invest in Kure Therapeutics Inc

Kure Therapeutics Inc

Healthcare
OKUR05 Dec 2024
-0.03 (-3.35%)
1M
3M
6M
1Y
5Y
Low
$14
Day’s Range
High
$14.75
14
52 Week Low
$9.8
52-Week Range
52 Week High
$77.6
9.8
1 Day
-
1 Week
-6%
1 month return
-9%
3 month return
-17.63%
6 month return
-17.63%
1 Year return
-
3 Years return
-
5 Years return
-
10 Years return
-

Market Status

Fundamentals
Market Cap
0
PB Ratio
0
PE Ratio
0
Enterprise Value
0
Total Assets
35.73 mln
Volume

Fund house & investment objective

Company Information
OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers. Its lead product candidate includes OKI-219, a selective inhibitor of phosphoinositide 3 kinase alpha harboring the H1047R mutation for the treatment of solid tumors, including breast cancer. The company is headquartered in Boulder, Colorado.
Organisation
Kure Therapeutics Inc
Employees
0
Industry
Biotechnology
CEO
Dr. Nicholas A. Saccomano Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step